A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population

RecruitingOBSERVATIONAL
Enrollment

355

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

October 8, 2026

Study Completion Date

October 8, 2026

Conditions
Asthma
Trial Locations (21)

Unknown

RECRUITING

Research Site, Chengdu

NOT_YET_RECRUITING

Research Site, Beijing

NOT_YET_RECRUITING

Research Site, Changsha

NOT_YET_RECRUITING

Research Site, Dongguan

NOT_YET_RECRUITING

Research Site, Foshan

NOT_YET_RECRUITING

Research Site, Guangzhou

NOT_YET_RECRUITING

Research Site, Hainan

NOT_YET_RECRUITING

Research Site, Hohhot

NOT_YET_RECRUITING

Research Site, Huizhou

NOT_YET_RECRUITING

Research Site, Kunming

NOT_YET_RECRUITING

Research Site, Nanjing

NOT_YET_RECRUITING

Research Site, Nanning

NOT_YET_RECRUITING

Research Site, Shanghai

NOT_YET_RECRUITING

Research Site, Shenyang

RECRUITING

Research Site, Taiyuan

NOT_YET_RECRUITING

Research Site, Wenzhou

RECRUITING

Research Site, Wuhan

RECRUITING

Research Site, Xi'an

NOT_YET_RECRUITING

Research Site, Xuzhou

NOT_YET_RECRUITING

Research Site, Zhanjiang

NOT_YET_RECRUITING

Research Site, Zhaoqing

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY